跳至主要内容
临床试验/ACTRN12614000046606
ACTRN12614000046606已完成1 期

The relationship between cognitive-motor impulsivity, dopaminergic genotype and dopamine agonist medication in healthy individuals

Professor Winston Byblow0 个研究点目标入组 33 人开始时间: 2014年1月17日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
40 Years 至 75 Years(—)
性别
All

入选标准

  • Between 40 and 75 years of age.
  • No neurological disease or disorder.
  • Normal or corrected to normal vision.

排除标准

  • Cognitive impairment (MoCA score below 26); unable to provide informed consent; any contraindications to the medications or placebo. Contraindications include: a known hypersensitivity to ropinirole, domperidone, or any of the excipients; history of acute or chronic psychiatric disorder; history of severe cardiac, hepatic or renal disease; history of severe systemic disease; history of severe dizziness or fainting; a prolactin-releasing pituitary tumour; currently breast feeding; current tobacco smoking or nicotine patch; lactose intolerance; glucose/galactose malabsorption and any medications which may interact with ropinirole or domperidone, or themselves cause drowsiness.

研究者

发起方
Professor Winston Byblow

相似试验